The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized double-blind placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with adavosertib in women with recurrent, platinum resistant epithelial ovarian cancer: A trial of the Princess Margaret, California, Chicago and Mayo Phase II Consortia.
 
Stephanie Lheureux
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca
Research Funding - AstraZeneca (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Michael Cabanero
No Relationships to Disclose
 
Mihaela C. Cristea
Honoraria - AstraZeneca; Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - AstraZeneca
Research Funding - Trovagene
 
Gina Mantia-Smaldone
Consulting or Advisory Role - Tesaro
 
Alexander Olawaiye
Consulting or Advisory Role - plasma surgical
 
Susan Ellard
Stock and Other Ownership Interests - Abbvie; AstraZeneca (I); Bristol-Myers Squibb; GlaxoSmithKline (I); Pfizer
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - Astellas Pharma; Ipsen
 
Johanne I Weberpals
Consulting or Advisory Role - AstraZeneca
Research Funding - Abbvie
 
Andrea Elisabeth Wahner Hendrickson
No Relationships to Disclose
 
Gini F. Fleming
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); Corcept Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Syndax (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)
 
Stephen Welch
Honoraria - Amgen; AstraZeneca; Celgene; Ipsen
 
Neesha C. Dhani
Honoraria - Celgene; Sanofi
Consulting or Advisory Role - Celgene; Incyte
 
Anna Piskorz
No Relationships to Disclose
 
Susie Tan
No Relationships to Disclose
 
Karen Chang
No Relationships to Disclose
 
Lisa Wang
No Relationships to Disclose
 
Charles Kunos
No Relationships to Disclose
 
Trevor John Pugh
Honoraria - Chrysalis Biomedical Advisors; Merck; Prosigna
Consulting or Advisory Role - DynaCare
Research Funding - Boehringer Ingelheim (Inst)
Patents, Royalties, Other Intellectual Property - Combined hybrid-capture DNA sequencing for disease detection; Hybrid-capture sequencing for dete rmining immune cell clonality
 
James D. Brenton
Stock and Other Ownership Interests - Inivata
Consulting or Advisory Role - Inivata
Speakers' Bureau - AstraZeneca
Research Funding - Aprea AB (Inst)
Patents, Royalties, Other Intellectual Property - TAm-Seq v2 method for ctDNA estimation
Travel, Accommodations, Expenses - Aprea AB; Aprea AB; Clovis Oncology
 
Amit M. Oza
Honoraria - Intas
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro